@article{ba95436dfa684aebac76bbb5182f7f11,
title = "Fostering Scientific Innovation to Impact AKI: A Roadmap from ASN's AKINow Basic Science Workgroup",
keywords = "AKINow, Acute kidney injury, Acute kidney injury and ICU nephrology, basic science",
author = "Parikh, {Samir M.} and Anupam Agarwal and Amandeep Bajwa and Sanjeev Kumar and Mansour, {Sherry G.} and Okusa, {Mark D.} and Jorge Cerda and Jorge Cerda and Anupam Agarwal and Erin Barreto and Stuart Goldstein and Kathleen Liu and Jay Koyner and Sherry Mansour and Javier Neyra and Mark Okusa and Marlies Osterman and Samir Parikh and Anitha Vijayan",
note = "Funding Information: Health care costs and resource utilization for managing hospitalized patients with AKI are estimated to be between $5.4 and $24 billion annually (). However, the investment of research funding from the National Institute of Health for kidney disease including AKI is significantly lower compared with the support for cancer, diabetes, heart disease, or HIV/AIDS (). The coronavirus disease 2019 pandemic has highlighted the effect of kidney involvement in hospitalized patients requiring RRT that resulted in unprecedented stress on major health systems. ",
year = "2022",
month = aug,
day = "25",
doi = "10.34067/KID.0007472021",
language = "English (US)",
volume = "3",
pages = "1445--1448",
journal = "Kidney360",
issn = "2641-7650",
publisher = "Lippincott Williams and Wilkins",
number = "8",
}